Literature DB >> 29255097

We need to mandate drug cost transparency on electronic medical records.

Iris Gorfinkel1, Joel Lexchin2.   

Abstract

Mesh：

Year:  2017        PMID： 29255097      PMCID： PMC5738246          DOI： 10.1503/cmaj.171070

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  6 in total

1.  Physicians' attitudes about prescribing and knowledge of the costs of common medications.

Authors:  S Reichert; T Simon; E A Halm
Journal:  Arch Intern Med       Date:  2000-10-09

2.  "Breakthrough" drugs and growth in expenditure on prescription drugs in Canada.

Authors:  Steven G Morgan; Kenneth L Bassett; James M Wright; Robert G Evans; Morris L Barer; Patricia A Caetano; Charlyn D Black
Journal:  BMJ       Date:  2005-09-02

3.  Effect of electronic prescribing with formulary decision support on medication use and cost.

Authors:  Michael A Fischer; Christine Vogeli; Margaret Stedman; Timothy Ferris; M Alan Brookhart; Joel S Weissman
Journal:  Arch Intern Med       Date:  2008-12-08

4.  Drug prices and third party payment: do they influence medication selection?

Authors:  J E Hux; C D Naylor
Journal:  Pharmacoeconomics       Date:  1994-04       Impact factor: 4.981

5.  Out-of-pocket costs and adherence to antihypertensive agents among older adults covered by the public drug insurance plan in Quebec.

Authors:  Raymond Milan; Helen-Maria Vasiliadis; Samantha Gontijo Guerra; Djamal Berbiche
Journal:  Patient Prefer Adherence       Date:  2017-09-08       Impact factor: 2.711

6.  Giving formulary and drug cost information to providers and impact on medication cost and use: a longitudinal non-randomized study.

Authors:  Chien-Wen Tseng; Grace A Lin; James Davis; Deborah A Taira; Jinoos Yazdany; Qimei He; Randi Chen; Allison Imamura; R Adams Dudley
Journal:  BMC Health Serv Res       Date:  2016-09-21       Impact factor: 2.655
  6 in total
  4 in total

1. 

Authors:  Iris Gorfinkel; Ahuva Brown; Joel R Lexchin
Journal:  Can Fam Physician       Date:  2020-10       Impact factor: 3.275

2.  Engaging physicians to prescribe more cost-effectively: Blueprint for change.

Authors:  Iris Gorfinkel; Ahuva Brown; Joel R Lexchin
Journal:  Can Fam Physician       Date:  2020-10       Impact factor: 3.275

3.  The consequences of patient charges for prescription drugs in Canada: a cross-sectional survey.

Authors:  Michael R Law; Lucy Cheng; Ashra Kolhatkar; Laurie J Goldsmith; Steven G Morgan; Anne M Holbrook; Irfan A Dhalla
Journal:  CMAJ Open       Date:  2018-02-05

4.  Does price disclosure in pharmaceutical advertising result in price transparency? Evidence from a randomized experiment.

Authors:  Ilene L Hollin; Jennifer Gerard Ball
Journal:  Explor Res Clin Soc Pharm       Date:  2022-09-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.